By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



505 Coast Boulevard South
Suite 209
La Jolla  California  92037  U.S.A.
Phone: 858-952-5500 Fax: 858-952-5490



Company News
CalciMedica Receives Fast-Track Designation For CM4620, A Novel CRAC Channel Inhibitor To Treat Acute Pancreatitis 5/25/2017 7:25:47 AM
CalciMedica Initiates Phase 1 Clinical Studies For CRAC Channel Inhibitor 1/6/2017 7:06:22 AM
CalciMedica And University of Liverpool Announce Publication On CRAC Channel Inhibitors For Acute Pancreatitis 7/27/2015 9:41:54 AM
CalciMedica Appoints Michael Dunn as SVP, Corporate Development 8/20/2013 6:18:03 AM
CalciMedica Moves Psoriasis Drug Into Clinic, Pockets $6M 2/17/2011 6:54:59 AM
CalciMedica Appoints Steven L. Schoenfeld, MD, as Vice President, Clinical Development 6/23/2010 11:18:53 AM
CalciMedica Achieves Milestone and Draws Down Second Tranche of $12 Million Series C Financing 12/15/2009 8:50:48 AM
CalciMedica Appoints Evelyn Graham to its Board of Directors 10/13/2009 10:54:26 AM
CalciMedica Raising $4 Million Series C Round 12/18/2008 8:00:26 AM
TorreyPines Therapeutics, Inc. (TPTX) (Jobs) Transfers Intellectual Property and Compounds for Treating Autoimmune Diseases to CalciMedica 5/7/2007 9:47:53 AM